Every revenue cycle vendor now has an AI story. Fewer denials, autonomous coding, appeals written in seconds. But if you set the pitch decks aside and look strictly at peer-reviewed research from the past two years, a far clearer, and more practical picture emerges.
AI is undoubtedly earning its place in the revenue cycle, but the strongest and most sustainable results happen when it operates alongside human experts. The organizations seeing lasting gains built human oversight directly into their workflow from the start, rather than treating it as a temporary safety net to be phased out later.
Areas where AI is driving measurable gains
Proactively catching
denials
Studies prove that simpler machine learning models predict claim denials just as effectively as complex algorithms. For revenue cycle teams, the key takeaway is that clean data, solid workflows, and catching eligibility issues during registration matter far more than algorithmic complexity.
Prioritizing high-value
appeals
At a leading Pennsylvania integrated health system, a machine learning model ranked denied hospital admissions by their likelihood of being overturned, helping physician advisors prioritize appeals more strategically. Combined with concurrent updates to their overall appeal strategy, this approach nearly doubled appeal and overturned volumes.
Improving coding
accuracy
While standalone LLMs often hallucinate billing codes, Mount Sinai researchers reduced these errors by grounding the AI in similar historical cases. In a retrospective study of 500 emergency visits, blinded physicians reviewers found the AI's codes accurate in 447 cases, compared to 277 cases coded manually by providers.
Translating better documentation into revenue
Beyond reducing burnout, ambient AI scribes also boost revenue. At UCSF Health, physicians using scribes billed 5.8% more RVUs per week and saw 2.8% more patients without increasing claim denials, generating roughly $3,000 in extra annual revenue per physician at Medicare rates.
Areas where evidence is thin for the impact of AI in RCM
These promising results come with real caveats that health system leaders should weigh before signing a vendor contract.
Most studies are small and retrospective
Nearly all published research relies on historical data from a single health system or payer. When one denial prediction model was tested on clinicians outside its original training group, its accuracy dropped noticeably.
Metrics aren’t standardized
None of the studies used HFMA’s standardized MAP Keys to measure success. How you count matters: in one study, the same dataset yielded a 31.9% denial rate by claim line, but a 42.5% denial rate by dollar volume.
Accurate capture vs upcoding
Higher RVUs from AI scribes could reflect more thorough notes, or more aggressive coding. However, relying on scribes can inflate billing intensity, raise patient costs, and could trigger regulatory payment cuts.
Prior authorization research favors payers
A 2026 review found that most prior authorization AI studies focus on predicting payer decisions, while very few measure whether patients actually get care faster.
The front end is almost untouched
Many denials originate during eligibility verification, registration, and patient collections, yet there is almost no peer-reviewed research proving that current AI tools work there.
Human-in-the-loop is the real differentiator
The central takeaway is that AI delivers the greatest value when paired with meaningful human oversight. Medical coders using AI assistants reduce coding time by ~40% while identifying nearly three times as many missing codes. Similarly, AI can prioritize denial risks, and ambient scribes can draft clinical notes, but human experts retain responsibility for final decisions and sign-off.
The risk increases when human oversight disappears. A major healthcare organization faced a class-action lawsuit alleging that its nH Predict algorithm had a 90% error rate in Medicare Advantage coverage denials, with staff failing to provide meaningful review. Although these remain allegations, the case highlights why human reviewers must do more than rubber-stamp AI-generated decisions.
However, effective oversight requires resources. One denial-prediction study found that routing the 20% riskiest claims to specialists identified roughly half of all denials, with a manageable level of false positives. Expanding review to 30% caught more denials but substantially increased false alarms. Revenue cycle leaders must therefore balance AI-driven efficiency with the cost and capacity required for meaningful human review.
A practical playbook to combine human expertise with technology
If your goal is achieving best-practice performance on HFMA’s MAP Keys, here is where the evidence shows a human expert still belongs in the workflow.
|
If you're working on…
|
Let AI…
|
Keep human expertise for…
|
|---|---|---|
|
Initial denial rate and clean claims
|
Score claims for denial risk before submission
|
Reviewing the flagged queue and updating rules as payer policies change
|
|
Coding accuracy and DNFB
|
Suggest codes grounded in similar past cases
|
Reviewing complex, inpatient, and E/M- or HCC-sensitive claims, with regular compliance audits
|
|
Denials overturned and time to appeal
|
Rank denials by overturn odds and draft appeal packets
|
Deciding what to appeal and validating every clinical argument and citation
|
|
Prior authorization
|
Check submission readiness and predict outcomes
|
Reviewing any adverse determination with a qualified clinician
|
|
Cost to collect
|
Automate routine, high-volume tasks
|
Measuring review time so oversight doesn't quietly eat the savings
|
Three principles to tie it together:
- Route work by confidence: Automate clear-cut cases and route everything else to a qualified expert.
- Learn from every override: Treat human corrections as training and actively watch for model drift as payer behavior shifts.
- Report results in MAP Key terms. If a vendor can’t show results using HFMA’s standard definitions, you have no fair way to compare them against competitors.
Building an AI-powered, human-enabled revenue cycle
AI in the revenue cycle is real, and the early numbers are encouraging. Research supports using AI as a sorting, predicting, and drafting layer, with accountable experts taking decisions that carry clinical, financial, and compliance risk.
At IKS Health, our AI-powered, human-enabled revenue cycle management services put this research into practice. Automation verifies eligibility, flags prior authorization gaps, suggests codes, and scores claims for denial risk. Meanwhile, our patient access specialists, certified coders, and denials teams step in on high-risk cases to make judgement calls that matter. Every correction feeds back into our models, making the system sharper over time.
Before your next RCM AI investment, ask three critical questions. Where exactly does a human review the output? How will performance be measured against HFMA MAP Keys? And how will oversight impact your team’s daily workload?
The real payoff goes beyond metrics. It gives people their time back. When data, workflows, and teams work in sync, administrative billing fades into the background, freeing your staff and clinicians to focus on patient care.
We welcome the chance to answer all three questions for your health system, from how our specialists govern complex claims to how we track the MAP Key metrics you care most about. Talk to the IKS Health team to see what this partnership could look like for your organization.